Skip to main content
. 2023 Jan 24;83(3):249–263. doi: 10.1007/s40265-022-01822-z

Fig. 2.

Fig. 2

On-treatment calibrated hazard ratio (HR) estimates for coronavirus disease 2019 (COVID-19) outcomes in users of ibuprofen versus comparator analgesics. CI confidence interval, COX-2i cyclooxygenase-2 inhibitors, ns-NSAIDs non-selective non-steroidal anti-inflammatory drugs